-transparent.png){kind=logo}
The influence of a number of clinical characteristics on the population pharmacokinetics of gentamicin were examined using routine drug-monitoring data from a group of 113 neonates. The data were analyzed using the programme NONMEM. Clearance was 0.053 litres.h-1.kg-1 and was reduced in neonates with postconceptional age less than or equal to 34 weeks (X 0.83) and 5-min Apgar score less than 7 (X 0.82). Volume of distribution was 0.47 litres.kg-1. These population mean parameter estimates were used to generate dosage regimens to achieve concentrations within the therapeutic range.
Related Publications
A H Thomson, and
S Way, and
S M Bryson, and
E M McGovern, and
A W Kelman, and
B Whiting
January 1992,
Pharmacotherapy,
A H Thomson, and
S Way, and
S M Bryson, and
E M McGovern, and
A W Kelman, and
B Whiting
August 2002,
Therapeutic drug monitoring,
A H Thomson, and
S Way, and
S M Bryson, and
E M McGovern, and
A W Kelman, and
B Whiting
April 2013,
Therapeutic drug monitoring,
A H Thomson, and
S Way, and
S M Bryson, and
E M McGovern, and
A W Kelman, and
B Whiting
November 2018,
Pharmacotherapy,
A H Thomson, and
S Way, and
S M Bryson, and
E M McGovern, and
A W Kelman, and
B Whiting
January 1993,
European journal of clinical pharmacology,
A H Thomson, and
S Way, and
S M Bryson, and
E M McGovern, and
A W Kelman, and
B Whiting
May 1980,
The Journal of pediatrics,
A H Thomson, and
S Way, and
S M Bryson, and
E M McGovern, and
A W Kelman, and
B Whiting
October 1999,
Therapeutic drug monitoring,
A H Thomson, and
S Way, and
S M Bryson, and
E M McGovern, and
A W Kelman, and
B Whiting
April 2003,
Therapeutic drug monitoring,
A H Thomson, and
S Way, and
S M Bryson, and
E M McGovern, and
A W Kelman, and
B Whiting
November 1997,
Critical care medicine,
A H Thomson, and
S Way, and
S M Bryson, and
E M McGovern, and
A W Kelman, and
B Whiting
August 1990,
The Pediatric infectious disease journal,
